A genomes-to-vaccine strategy for rational vaccine design rests on two premises:
- A minimal set of immunogens that induces a robust and sustained immune response to a pathogen can be discovered using high throughput methods.
- Administration of these immunogens, in a suitable delivery vehicle together with adjuvant, will protect against infection or disease.
